R W Sutter
Overview
Explore the profile of R W Sutter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Macklin G, OReilly K, Grassly N, Edmunds W, Mach O, Santhana Gopala Krishnan R, et al.
Science
. 2020 Mar;
368(6489):401-405.
PMID: 32193361
Although there have been no cases of serotype 2 wild poliovirus for more than 20 years, transmission of serotype 2 vaccine-derived poliovirus (VDPV2) and associated paralytic cases in several continents...
2.
Habib M, Soofi S, Sheraz A, Bhatti Z, Okayasu H, Zaidi S, et al.
Vaccine
. 2014 Dec;
33(6):819-25.
PMID: 25500307
Background: Polio eradication remains a challenge in Pakistan and the causes for the failure to eradicate poliomyelitis are complex. Undernutrition and micronutrient deficiencies, especially zinc deficiency, are major public health...
3.
Habib M, Soofi S, Ali N, Sutter R, Palansch M, Qureshi H, et al.
Vaccine
. 2013 Feb;
31(15):1987-93.
PMID: 23429005
Background: Seroprevalence studies provide important data on performance of immunization programs, susceptible groups and populations at-risk of future outbreaks. Identifying risk factors that affect seroconversion of the oral polio vaccine...
4.
Sutter R, Maher C
Curr Top Microbiol Immunol
. 2006 Sep;
304:195-220.
PMID: 16989271
Effective vaccines against poliomyelitis became available in the mid-1950s and early 1960s. Mass campaigns were an integral part of early control efforts. Thereafter, polio vaccines were used largely in routine...
5.
Prevots D, Burr R, Sutter R, Murphy T
MMWR Recomm Rep
. 2004 Dec;
49(RR-5):1-22.
PMID: 15580728
These recommendations of the Advisory Committee on Immunization Practices (ACIP) for poliomyelitis prevention replace those issued in 1997. As of January 1, 2000, ACIP recommends exclusive use of inactivated poliovirus...
6.
Cochi S, Sutter R, Aylward R
Dev Biol (Basel)
. 2002 Jan;
105:153-8; discussion 159.
PMID: 11763323
One of the challenges of the polio eradication initiative over the next few years will be the formulation of an optimal strategy for stopping poliovirus vaccination after global certification of...
7.
Fine P, Sutter R, Orenstein W
Dev Biol (Basel)
. 2002 Jan;
105:129-47; discussion 149-50.
PMID: 11763322
No abstract available.
8.
Lago P, Caceres V, Galindo M, Gary Jr H, Valcarcel M, Barrios J, et al.
Int J Epidemiol
. 2001 Nov;
30(5):1029-34.
PMID: 11689516
Background: With substantial progress made toward polio eradication, developing the appropriate strategy for discontinuing global oral poliovirus vaccine (OPV) after global eradication becomes increasingly important. At issue is the theoretical...
9.
Caceres V, Sutter R
Clin Infect Dis
. 2001 Jul;
33(4):531-41.
PMID: 11462191
After global eradication of polio is achieved, there will be a need for stockpiles of vaccine to combat potential outbreaks of poliomyelitis caused by (1) unforeseen release of polioviruses, (2)...
10.
Sutter R, Tangermann R, Aylward R, Cochi S
Infect Dis Clin North Am
. 2001 Apr;
15(1):41-64.
PMID: 11301822
In 1988, the World Health Assembly resolved to eradicate poliomyelitis globally by the year 2000. Dramatic progress toward this goal has occurred: three of the six WHO regions (Region of...